Latest filing published 16 Feb 2022 for Phio Pharmaceuticals Corp..
Insider track record
No signal scores available.
H. Paul Dorman: trading record in brief
H. Paul Dorman is a declared insider of Phio Pharmaceuticals Corp. (board member), with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 2 June 2015 and the latest from 15 February 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 16 February 2022 came the latest disclosure, a share grant in Phio Pharmaceuticals Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to H. Paul Dorman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common stock, $0.0001 par valueSEC:0001209191-22-010388:0
- 10,000 shares0Common stock, $0.0001 par valueSEC:0001209191-21-017575:0
- 10,000 shares0Common stockSEC:0001209191-19-010827:0
- 10,000 shares0Common StockSEC:0001209191-18-045459:0
- 37,500 shares@ US$0.40Common stock, $0.0001 par valueSEC:0001209191-15-049285:0
5 of 5 declarations
